Economic consequences of molecular profiling for metastatic solid tumors. Cost-effectiveness of pazopanib (PAZ) versus sunitinib (SUN) as first-line treatment of metastatic renal cell carcinoma (mRCC) ...
Panitumumab activity in metastatic colorectal cancer (mCRC) patients (pts) with low or negative tumor epidermal growth factor receptor (EGFr) levels: An updated analysis No significant financial ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, No. 14 (April 5, 2022), pp. 1-11 (11 pages) Coenzymes distribute a variety of chemical moieties throughout ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results